Therapeutic Vaccines Market Size by Product, Technology, Vaccine Type, End-User, Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2032
15.44%
CAGR (2025-2032)
84.96 USD Bn.
Market Size
323
Report Pages
145
Market Tables
Overview
Therapeutic Vaccines Market size was valued at USD 84.96 Bn in 2024, and the Therapeutic Vaccines Market revenue is expected to grow at a CAGR of 15.44% from 2025 to 2032, reaching nearly USD 267.96 Bn.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding the global market dynamics, structure by identifying and analysing the market segments and project the global market size.
To know about the Research Methodology :- Request Free Sample Report
The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the global market.
Global therapeutic vaccines market is fixed to witness great growth opportunities in recent times. This can be attributed to the increasing awareness of communicable diseases and new threats, cost-effectiveness of vaccines, development in new research techniques and growing demand, new target population and the emergence of developing markets. The major driving factor such as the increasing occurrence of cancer, cardiovascular diseases, HIV infection and several chronic diseases are boosting the market.
In addition, Increase in funding’s from the government for vaccine development and growing awareness among people for severe disease are the key factors escalating the growth of global therapeutic vaccines market. With the increasing demand for different types of vaccines to be introduced into the market, there is one restraint to this situation. The vaccine research requires huge capital to be invested and a lot of time to be spent.
Therapeutic Vaccines Market Segmentation Analysis
Based on Product, The Global Therapeutic Vaccines Market can be segmented, by product type, into the following 4 key subsegments: addiction vaccines, autoimmune disease vaccines, infectious disease vaccines, and neurological disease vaccines. Each represent a niche strategy - using immune-based therapies to manage disease or shape the disease path.
The autoimmune disease vaccines segment, however, is leading all other segments. This is mainly due to the increasing incidence of autoimmune diseases, including rheumatoid arthritis, type I diabetes mellitus, and multiple sclerosis, creating a rise in immune-modulating treatment that users can use as an alternative long-term treatment.
Region-wise, North America represents developed regional markets for therapeutic vaccines and is anticipated to see the rapid growth in the upcoming years. The US is by far the leading therapeutic vaccine market by country in North America. The US market is predictable to grow at the highest CAGR during the forecast period. This growth is mainly owing to the well-developed healthcare infrastructure and increases in research and development on a therapeutic vaccine. Additionally, the disposable income and reimbursement of life-threatening diseases are very high in this region which promotes the growth of global therapeutic vaccine market. Europe was the second largest regional market and is estimated to show significant growth in the years to come. This growth is mainly as of increase in a number of patients diagnosed with cancer.
Scope Global Therapeutic Vaccines Market: Inquire before buying
| Global Therapeutic Vaccines Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2024 | Forecast Period: | 2025-2032 |
| Historical Data: | 2019 to 2024 | Market Size in 2024: | USD 84.96 Bn. |
| Forecast Period 2025 to 2032 CAGR: | 15.44% | Market Size in 2032: | USD 267.96 Bn. |
| Segments Covered: | by Product | Addiction Vaccines Autoimmune Disease Vaccines Infectious Disease Vaccines Neurological Disease Vaccines |
|
| by Technology | Autologous vaccines Allogeneic vaccines |
||
| by Vaccine Type | Tumour Cell Vaccines Antigen/Peptide-based Vaccines Dendritic Cell Vaccines DNA Vaccines RNA/mRNA-based Vaccines Virus-like Particle (VLP) / Vector-based Vaccines Others |
||
| by End-User | Hospitals Hospital Pharmacies Retail Pharmacies Online Pharmacies |
||
Therapeutic Vaccines Market, by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Key players operating in Global Therapeutic Vaccines Market
1. Sanofi-Pasteur
2. Cytos Biotechnology AG
3. Intellect Neurosciences
4. Agenus Inc.
5. Celtic Pharma,
6. Novartis
7. Dendreon Corp.
8. Pfizer
9. Transgene
10. Antigenics
11. Argos Therapeutics
12. Bavarian Nordic
13. Biovest International
14. Celldex Therapeutics
15. Cel-Sci
16. Curevac
17. GlaxoSmithKline
18. Merck & Co.
19. Vaccinogen Inc.
20. Affiris
21. Medimmune, LLC
Frequently Asked Questions:
1. Which region has the largest share in Global Therapeutic Vaccines Market?
Ans: Asia Pacific region holds the highest share in 2024.
2. What is the growth rate of Global Therapeutic Vaccines Market?
Ans: The Global Therapeutic Vaccines Market is growing at a CAGR of 15.44% during forecasting period 2024-2032.
3. What is scope of the Global Therapeutic Vaccines Market report?
Ans: Global Therapeutic Vaccines Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. What is the study period of market?
Ans: The Global TMarket is studied from 2024 to 2032.
Table of Contents
1. Therapeutic Vaccines Market Introduction
1.1. Study Assumption and Market Definition
1.2. Scope of the Study
1.3. Executive Summary
2. Global Therapeutic Vaccines Market: Competitive Landscape
2.1. MMR Competition Matrix
2.2. Competitive Landscape
2.3. Key Players Benchmarking
2.3.1. Company Name
2.3.2. Business Segment
2.3.3. End-user Segment
2.3.4. Revenue (2024)
2.3.5. Company Locations
2.4. Leading Therapeutic Vaccines Market Companies, by market capitalization
2.5. Market Structure
2.5.1. Market Leaders
2.5.2. Market Followers
2.5.3. Emerging Players
2.6. Mergers and Acquisitions Details
3. Therapeutic Vaccines Market: Dynamics
3.1. Therapeutic Vaccines Market Trends by Region
3.1.1. North America Therapeutic Vaccines Market Trends
3.1.2. Europe Therapeutic Vaccines Market Trends
3.1.3. Asia Pacific Therapeutic Vaccines Market Trends
3.1.4. Middle East and Africa Therapeutic Vaccines Market Trends
3.1.5. South America Therapeutic Vaccines Market Trends
3.2. Therapeutic Vaccines Market Dynamics by Region
3.2.1. North America
3.2.1.1. North America Therapeutic Vaccines Market Drivers
3.2.1.2. North America Therapeutic Vaccines Market Restraints
3.2.1.3. North America Therapeutic Vaccines Market Opportunities
3.2.1.4. North America Therapeutic Vaccines Market Challenges
3.2.2. Europe
3.2.2.1. Europe Therapeutic Vaccines Market Drivers
3.2.2.2. Europe Therapeutic Vaccines Market Restraints
3.2.2.3. Europe Therapeutic Vaccines Market Opportunities
3.2.2.4. Europe Therapeutic Vaccines Market Challenges
3.2.3. Asia Pacific
3.2.3.1. Asia Pacific Therapeutic Vaccines Market Drivers
3.2.3.2. Asia Pacific Therapeutic Vaccines Market Restraints
3.2.3.3. Asia Pacific Therapeutic Vaccines Market Opportunities
3.2.3.4. Asia Pacific Therapeutic Vaccines Market Challenges
3.2.4. Middle East and Africa
3.2.4.1. Middle East and Africa Therapeutic Vaccines Market Drivers
3.2.4.2. Middle East and Africa Therapeutic Vaccines Market Restraints
3.2.4.3. Middle East and Africa Therapeutic Vaccines Market Opportunities
3.2.4.4. Middle East and Africa Therapeutic Vaccines Market Challenges
3.2.5. South America
3.2.5.1. South America Therapeutic Vaccines Market Drivers
3.2.5.2. South America Therapeutic Vaccines Market Restraints
3.2.5.3. South America Therapeutic Vaccines Market Opportunities
3.2.5.4. South America Therapeutic Vaccines Market Challenges
3.3. PORTER’s Five Forces Analysis
3.4. PESTLE Analysis
3.5. Technology Roadmap
3.6. Regulatory Landscape by Region
3.6.1. North America
3.6.2. Europe
3.6.3. Asia Pacific
3.6.4. Middle East and Africa
3.6.5. South America
3.7. Key Opinion Leader Analysis For Therapeutic Vaccines Industry
3.8. Analysis of Government Schemes and Initiatives For Therapeutic Vaccines Industry
3.9. Therapeutic Vaccines Market Trade Analysis
3.10. The Global Pandemic Impact on Therapeutic Vaccines Market
4. Therapeutic Vaccines Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2024-2032
4.1. Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
4.1.1. Addiction Vaccines
4.1.2. Autoimmune Disease Vaccines
4.1.3. Infectious Disease Vaccines
4.1.4. Neurological Disease Vaccines
4.2. Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
4.2.1. Autologous vaccines
4.2.2. Allogeneic vaccines
4.3. Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
4.3.1. Tumour Cell Vaccines
4.3.2. Antigen/Peptide-based Vaccines
4.3.3. Dendritic Cell Vaccines
4.3.4. DNA Vaccines
4.3.5. RNA/mRNA-based Vaccines
4.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
4.3.7. Others
4.4. Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
4.4.1. Hospitals
4.4.2. Hospital Pharmacies
4.4.3. Retail Pharmacies
4.4.4. Online Pharmacies
4.5. Therapeutic Vaccines Market Size and Forecast, by Region (2024-2032)
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. Middle East and Africa
4.5.5. South America
5. North America Therapeutic Vaccines Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032
5.1. North America Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
5.1.1. Addiction Vaccines
5.1.2. Autoimmune Disease Vaccines
5.1.3. Infectious Disease Vaccines
5.1.4. Neurological Disease Vaccines
5.2. North America Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
5.2.1. Autologous vaccines
5.2.2. Allogeneic vaccines
5.3. North America Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
5.3.1. Tumour Cell Vaccines
5.3.2. Antigen/Peptide-based Vaccines
5.3.3. Dendritic Cell Vaccines
5.3.4. DNA Vaccines
5.3.5. RNA/mRNA-based Vaccines
5.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
5.3.7. Others
5.4. North America Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
5.4.1. Hospitals
5.4.2. Hospital Pharmacies
5.4.3. Retail Pharmacies
5.4.4. Online Pharmacies
5.5. North America Therapeutic Vaccines Market Size and Forecast, by Country (2024-2032)
5.5.1. United States
5.5.1.1. United States Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
5.5.1.1.1. Addiction Vaccines
5.5.1.1.2. Autoimmune Disease Vaccines
5.5.1.1.3. Infectious Disease Vaccines
5.5.1.1.4. Neurological Disease Vaccines
5.5.1.2. United States Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
5.5.1.2.1. Autologous vaccines
5.5.1.2.2. Allogeneic vaccines
5.5.1.3. United States Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
5.5.1.3.1. Tumour Cell Vaccines
5.5.1.3.2. Antigen/Peptide-based Vaccines
5.5.1.3.3. Dendritic Cell Vaccines
5.5.1.3.4. DNA Vaccines
5.5.1.3.5. RNA/mRNA-based Vaccines
5.5.1.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
5.5.1.3.7. Others
5.5.1.4. United States Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
5.5.1.4.1. Hospitals
5.5.1.4.2. Hospital Pharmacies
5.5.1.4.3. Retail Pharmacies
5.5.1.4.4. Online Pharmacies
5.5.2. Canada
5.5.2.1. Canada Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
5.5.2.1.1. Addiction Vaccines
5.5.2.1.2. Autoimmune Disease Vaccines
5.5.2.1.3. Infectious Disease Vaccines
5.5.2.1.4. Neurological Disease Vaccines
5.5.2.2. Canada Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
5.5.2.2.1. Autologous vaccines
5.5.2.2.2. Allogeneic vaccines
5.5.2.3. Canada Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
5.5.2.3.1. Tumour Cell Vaccines
5.5.2.3.2. Antigen/Peptide-based Vaccines
5.5.2.3.3. Dendritic Cell Vaccines
5.5.2.3.4. DNA Vaccines
5.5.2.3.5. RNA/mRNA-based Vaccines
5.5.2.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
5.5.2.3.7. Others
5.5.2.4. Canada Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
5.5.2.4.1. Hospitals
5.5.2.4.2. Hospital Pharmacies
5.5.2.4.3. Retail Pharmacies
5.5.2.4.4. Online Pharmacies
5.5.3. Mexico
5.5.3.1. Mexico Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
5.5.3.1.1. Addiction Vaccines
5.5.3.1.2. Autoimmune Disease Vaccines
5.5.3.1.3. Infectious Disease Vaccines
5.5.3.1.4. Neurological Disease Vaccines
5.5.3.2. Mexico Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
5.5.3.2.1. Autologous vaccines
5.5.3.2.2. Allogeneic vaccines
5.5.3.3. Mexico Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
5.5.3.3.1. Tumour Cell Vaccines
5.5.3.3.2. Antigen/Peptide-based Vaccines
5.5.3.3.3. Dendritic Cell Vaccines
5.5.3.3.4. DNA Vaccines
5.5.3.3.5. RNA/mRNA-based Vaccines
5.5.3.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
5.5.3.3.7. Others
5.5.3.4. Mexico Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
5.5.3.4.1. Hospitals
5.5.3.4.2. Hospital Pharmacies
5.5.3.4.3. Retail Pharmacies
5.5.3.4.4. Online Pharmacies
6. Europe Therapeutic Vaccines Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032
6.1. Europe Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
6.2. Europe Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
6.3. Europe Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
6.4. Europe Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
6.5. Europe Therapeutic Vaccines Market Size and Forecast, by Country (2024-2032)
6.5.1. United Kingdom
6.5.1.1. United Kingdom Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
6.5.1.2. United Kingdom Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
6.5.1.3. United Kingdom Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
6.5.1.4. United Kingdom Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
6.5.2. France
6.5.2.1. France Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
6.5.2.2. France Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
6.5.2.3. France Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
6.5.2.4. France Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
6.5.3. Germany
6.5.3.1. Germany Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
6.5.3.2. Germany Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
6.5.3.3. Germany Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
6.5.3.4. Germany Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
6.5.4. Italy
6.5.4.1. Italy Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
6.5.4.2. Italy Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
6.5.4.3. Italy Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
6.5.4.4. Italy Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
6.5.5. Spain
6.5.5.1. Spain Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
6.5.5.2. Spain Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
6.5.5.3. Spain Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
6.5.5.4. Spain Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
6.5.6. Sweden
6.5.6.1. Sweden Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
6.5.6.2. Sweden Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
6.5.6.3. Sweden Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
6.5.6.4. Sweden Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
6.5.7. Austria
6.5.7.1. Austria Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
6.5.7.2. Austria Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
6.5.7.3. Austria Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
6.5.7.4. Austria Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
6.5.8. Rest of Europe
6.5.8.1. Rest of Europe Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
6.5.8.2. Rest of Europe Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
6.5.8.3. Rest of Europe Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
6.5.8.4. Rest of Europe Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
7. Asia Pacific Therapeutic Vaccines Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032
7.1. Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
7.2. Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
7.3. Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
7.4. Asia Pacific Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
7.5. Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Country (2024-2032)
7.5.1. China
7.5.1.1. China Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
7.5.1.2. China Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
7.5.1.3. China Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
7.5.1.4. China Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
7.5.2. S Korea
7.5.2.1. S Korea Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
7.5.2.2. S Korea Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
7.5.2.3. S Korea Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
7.5.2.4. S Korea Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
7.5.3. Japan
7.5.3.1. Japan Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
7.5.3.2. Japan Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
7.5.3.3. Japan Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
7.5.3.4. Japan Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
7.5.4. India
7.5.4.1. India Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
7.5.4.2. India Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
7.5.4.3. India Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
7.5.4.4. India Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
7.5.5. Australia
7.5.5.1. Australia Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
7.5.5.2. Australia Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
7.5.5.3. Australia Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
7.5.5.4. Australia Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
7.5.6. Indonesia
7.5.6.1. Indonesia Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
7.5.6.2. Indonesia Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
7.5.6.3. Indonesia Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
7.5.6.4. Indonesia Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
7.5.7. Malaysia
7.5.7.1. Malaysia Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
7.5.7.2. Malaysia Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
7.5.7.3. Malaysia Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
7.5.7.4. Malaysia Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
7.5.8. Vietnam
7.5.8.1. Vietnam Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
7.5.8.2. Vietnam Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
7.5.8.3. Vietnam Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
7.5.8.4. Vietnam Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
7.5.9. Taiwan
7.5.9.1. Taiwan Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
7.5.9.2. Taiwan Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
7.5.9.3. Taiwan Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
7.5.9.4. Taiwan Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
7.5.10. Rest of Asia Pacific
7.5.10.1. Rest of Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
7.5.10.2. Rest of Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
7.5.10.3. Rest of Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
7.5.10.4. Rest of Asia Pacific Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
8. Middle East and Africa Therapeutic Vaccines Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032
8.1. Middle East and Africa Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
8.2. Middle East and Africa Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
8.3. Middle East and Africa Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
8.4. Middle East and Africa Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
8.5. Middle East and Africa Therapeutic Vaccines Market Size and Forecast, by Country (2024-2032)
8.5.1. South Africa
8.5.1.1. South Africa Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
8.5.1.2. South Africa Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
8.5.1.3. South Africa Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
8.5.1.4. South Africa Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
8.5.2. GCC
8.5.2.1. GCC Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
8.5.2.2. GCC Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
8.5.2.3. GCC Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
8.5.2.4. GCC Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
8.5.3. Nigeria
8.5.3.1. Nigeria Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
8.5.3.2. Nigeria Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
8.5.3.3. Nigeria Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
8.5.3.4. Nigeria Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
8.5.4. Rest of ME&A
8.5.4.1. Rest of ME&A Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
8.5.4.2. Rest of ME&A Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
8.5.4.3. Rest of ME&A Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
8.5.4.4. Rest of ME&A Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
9. South America Therapeutic Vaccines Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032
9.1. South America Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
9.2. South America Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
9.3. South America Therapeutic Vaccines Market Size and Forecast, by Vaccine Type(2024-2032)
9.4. South America Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
9.5. South America Therapeutic Vaccines Market Size and Forecast, by Country (2024-2032)
9.5.1. Brazil
9.5.1.1. Brazil Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
9.5.1.2. Brazil Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
9.5.1.3. Brazil Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
9.5.1.4. Brazil Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
9.5.2. Argentina
9.5.2.1. Argentina Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
9.5.2.2. Argentina Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
9.5.2.3. Argentina Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
9.5.2.4. Argentina Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
9.5.3. Rest Of South America
9.5.3.1. Rest Of South America Therapeutic Vaccines Market Size and Forecast, by Product (2024-2032)
9.5.3.2. Rest Of South America Therapeutic Vaccines Market Size and Forecast, by Technology (2024-2032)
9.5.3.3. Rest Of South America Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2024-2032)
9.5.3.4. Rest Of South America Therapeutic Vaccines Market Size and Forecast, by End User (2024-2032)
10. Company Profile: Key Players
10.1. Sanofi-Pasteur
10.1.1. Company Overview
10.1.2. Business Portfolio
10.1.3. Financial Overview
10.1.4. SWOT Analysis
10.1.5. Strategic Analysis
10.1.6. Scale of Operation (small, medium, and large)
10.1.7. Details on Partnership
10.1.8. Regulatory Accreditations and Certifications Received by Them
10.1.9. Awards Received by the Firm
10.1.10. Recent Developments
10.2. Cytos Biotechnology AG
10.3. Intellect Neurosciences
10.4. Agenus Inc.
10.5. Celtic Pharma,
10.6. Novartis
10.7. Dendreon Corp.
10.8. Pfizer
10.9. Transgene
10.10. Antigenics
10.11. Argos Therapeutics
10.12. Bavarian Nordic
10.13. Biovest International
10.14. Celldex Therapeutics
10.15. Cel-Sci
10.16. Curevac
10.17. GlaxoSmithKline
10.18. Merck & Co.
10.19. Vaccinogen Inc.
10.20. Affiris
10.21. Medimmune, LLC
11. Key Findings
12. Industry Recommendations
13. Therapeutic Vaccines Market: Research Methodology
14. Terms and Glossary